Bibliographic information
GuidelineGuidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
Originally developed
FIRST-LINE ANTIVIRAL THERAPIES FOR CHRONIC HEPATITIS B. Nucleos(t)ide analogues (NAs) s with a low barrier to resistance (lamivudine, adefovir or telbivudine) can lead to drug resistance and are not recommended
Recommended against
Strong
Certainty of evidence
Moderate
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year2024
InstitutionWHO